Brain stimulation to help people stay on schizophrenia medications
Part of Mental health clinical trials.
This study tests whether a non-invasive brain stimulation treatment can improve medication adherence in people with schizophrenia or schizoaffective disorder. If it helps you take meds more reliably, it may also support more stable mental health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older (inpatient or outpatient).
- You have a diagnosis of schizophrenia or schizoaffective disorder.
- You can understand the study and say yes to participate.
- You have been on stable doses of your antipsychotic and other meds for at least 2 months, with no expected dose changes.
- You do not have major unstable medical/neurological problems, including a history of seizures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if combining a gentle brain stimulation technique (tACS) with talk therapy (CBT for psychosis) can help reduce symptoms in people with schizophrenia. You would keep taking your usual medications throughout the study.
This trial tests a brain-stimulation approach for people with schizophrenia (or schizoaffective disorder) who don’t always recognize how their illness affects them. It may help improve symptoms and insight while you stay on stable medications during the study.
This study tests whether a mild form of brain stimulation called tDCS (transcranial direct current stimulation) can help improve symptoms of schizophrenia or schizoaffective disorder. tDCS uses small electrodes on the scalp to gently stimulate brain areas involved in vision and thinking.
This trial tests a type of brain stimulation called TMS to see if it can change brain connections that may be linked to symptoms. It might help people with schizophrenia or schizoaffective disorder who are stable on their current medications.
This study tests a noninvasive brain stimulation treatment (tDCS) to improve thinking and memory problems in people with early schizophrenia. If you qualify, you would receive the study treatment while continuing stable schizophrenia care.
This study tests a brain stimulation treatment (neuromodulation) to improve brain connectivity in people with schizophrenia. It aims to see if this approach can help with symptoms and cognitive function.
Hear when a new Schizophrenia;Schizoaffective trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.